PMC · DOI:10.1136/bmjopen-2024-088474corr1·October 29, 2025
Correction: Participants’ perspectives of the advanced ovarian cancer biomarker study VALTIVE1: a qualitative study
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOvarian cancer diagnosis and treatment · PARP inhibition in cancer therapy · BRCA gene mutations in cancer